All

× UPDATE! Updated as of 05 April 2024.
Records 41 to 60 of 32212
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Classification
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-1091 Epoetin beta Recormon 2,000 I.U./0.3mL Solution for Injection (S.C./I.V.) Prescription Drug (Rx) Antianemic Preparations Roche Diagnostic GmbH Germany Renewal 18 September 2021 05 November 2026
View BR-1089 Measles, Mumps, Rubella and Varicella Vaccine (Live) Proquad Each dose (0.5 mL) contains: Measles virus (Edmonston B) 3.00 log TCID50* Mumps virus (Jeryl Lynn B level)4.30 log TCID50 Rubella virus (Wistar RA 27/3) 3.00 log TCID50 Varicella virus (Oka/Merck) 3.99 PFU** *50% Tissue Culture Infectious Dose **Plaque Forming Units Lyophilized Powder For Solution For Injection (SC) Prescription Drug (RX) Vaccines Merck Sharp & Dohme LLC U.S.A Initial (from Monitored Release) [Correction] 11 March 2024 09 June 2025
View BR-1093 Alteplase Actilyse 50 mg Powder for Solution for Infusion (IV Prescription Drug (RX) - Boehringer Ingelheim Pharma GmbH & Co. KG Germany Initial (Variation) 19 September 2022 19 September 2027
View BR-1096 Menothropin Menopur 1200 IU Lyophilized Powder For Injection (SC) Prescription Drug (RX) - Ferring GmbH Germany - 18 March 2022 26 June 2025
View BR-1098 Enoxaparin sodium Lomoh-60 60 mg/0.6 mL Solution for Injection (S.C.) Prescription (Rx) Drug Antithrombotic Agent Emcure Pharmaceuticals Ltd. India Renewal (Correction) 17 November 2023 30 June 2025
View BR-1099 Enoxaparin Sodium Lomoh - 40 40 mg/0.4 mL Solution For Injection (S.C.) Prescription Drug (RX) - Emcure Pharmaceuticals Ltd. India - 16 September 2021 30 June 2025
View BR-1101_PI_01.pdf BR-1101 Tocilizumab Actemra 162 mg/ 0.9 mL Solution For Injection (SC) Prescription Drug (RX) - Vetter Pharma-Fertigung GmbH & Co. KG Germany - 08 March 2022 28 July 2025
View BR-1102 Insulin Human (rDNA) Insuget-N 100 IU/mL Suspension for Injection (IM/SC) Prescription Drug (RX) - Getz Pharma Pvt. Ltd. Pakistan - 22 October 2020 06 January 2025
View BR-1103 Insulin Human (rDNA) Insuget-R 100 IU/mL Suspension for Injection (IM/IV/SC) Prescription Drug (RX) - Getz Pharma Pvt. Ltd. Pakistan - 22 October 2020 06 January 2025
View BR-1106 Insulin Human (rDNA) SciLin R 100 IU/mL Solution for Injection (IV/SC) Prescription Drug (RX) - Bioton S.A. Poland - 26 February 2021 28 January 2025
View BR-1107 Insulin Human (DNA) Scilin R 100 IU/mL Solution for Injection (IV/SC) Prescription Drug (RX) - Bioton S.A. Poland Renewal 18 October 2021 28 January 2025
View BR-1117 Heparin Sodium Heprin 5000IU/mL Solution For Injection (IV/SC) Prescription Drug (RX) - Gland Pharma Limited India Renewal 14 May 2021 25 May 2025
View BR-1121 Trastuzumab Herceptin 600 mg/ 5 mL (120 mg/ mL) Solution For Injection (SC) Prescription Drug (RX) - F. Hoffmann-La Roche AG Switzerland Regular Renewal (Compliance) 07 March 2022 29 September 2025
View BR-1122 Rituximab Mabthera 1400 mg/ 11.7 mL Solution For Injection (SC) Prescription Drug (RX) - F. Hoffman-La Roche AG Switzerland Regular Renewal (Compliance) 18 February 2022 29 September 2025
View BR-1123 Obinutuzumab Gazyva 1 g/40 mL (25mg/mL) Concentrate For Solution For Infusion (IV) Prescription Drug (RX) - Roche Diagnostics GmbH Germany Initial (Variation) 12 August 2022 12 August 2027
View BR-1126 Secukinumab Cosentyx 150 mg/mL Solution For Injection (SC) Prescription Drug (RX) - Novartis Pharma Stein AG Switzerland Initial (from Monitored Release) 12 April 2022 06 January 2026
View BR-1127 Secukinumab Scapho 150 mg Powder For Solution For Injection (SC) Prescription Drug (RX) - Novartis Pharma Stein AG, Pharmaceutical Switzerland - 07 April 2022 14 January 2026
View BR-1130_PI_01.pdf BR-1130 Secukinumab Scapho 150 mg/mL Solution For Injection (Sc) Prescription Drug (RX) - Novartis Pharma Stein AG, Pharmaceutical Switzerland Initial (from Monitored Release) 11 April 2022 06 January 2026
View BR-1133 Pneumococcal Conjugate Vaccine, 13-Valent (adsorbed) [See formulation on reverse side] Prevenar 13 0.5 mL Suspension For Injection (IM) Prescription Drug (RX) - Pfizer Ireland Pharmaceuticals Ireland - 10 September 2021 21 January 2026
View BR-1125_PI_01.pdf BR-1125 Quadrivalent Seasonal Influenza Vaccine (Split Virion, Inactivated) Southern Hemisphere 2024 Strain. Fluarix Tetra Each dose (0.5 mL) contains the following influenza strains*: A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238) A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022, IVR-237) B/Austria/1359417/2021-like strain (B/Austria/1359417/2021, BVR-26) B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type) [Yamagata lineage] *Propagated in embryonated chicken eggs **Haemagglutinin 15 μg of HA** 15 μg of HA** 15 μg of HA** 15 μg of HA** Suspension for Injection (IM) Prescription Drug (RX) Vaccines GlaxoSmithKline Biologicals NL Der SmithKline Germany Monitored Release (Strain Clearance) 19 February 2024 19 February 2025